- Home
- CRF vs IART Comparison
CRF vs IART Comparison
Compare CRF & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRF | IART |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 933.9M |
| IPO Year | 1997 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CRF | IART |
|---|---|---|
| Price | $7.41 | $10.46 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | ★ 1.7M | 688.6K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.45 |
| Revenue Next Year | N/A | $3.57 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.81 | $10.60 |
| 52 Week High | $8.25 | $24.37 |
Technical Indicators
Market Signals| Indicator | CRF | IART |
|---|---|---|
| Relative Strength Index (RSI) | 43.44 | 36.16 |
| Support Level | $6.76 | N/A |
| Resistance Level | $8.01 | $14.14 |
| Average True Range (ATR) | 0.21 | 0.60 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 63.00 | 4.50 |
Price Performance
Historical ComparisonAbout CRF Cornerstone Total Return Fund Inc. (The)
Cornerstone Total Return Fund Inc is a diversified closed-end management company. Its objective is to seek capital appreciation with current income as a secondary objective. The company invests in sectors such as Information Technology; Health Care; Financials; Communication Services; Consumer Discretionary; Industrials; Exchange-Traded Funds; Utilities; Energy; Real Estate and others.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.